Postoperative hemorrhage and hospital revisit after transoral robotic surgery
- PMID: 28425577
- PMCID: PMC7050677
- DOI: 10.1002/lary.26626
Postoperative hemorrhage and hospital revisit after transoral robotic surgery
Abstract
Objectives/hypothesis: To investigate the incidence and complications related to postoperative hemorrhage (POH) after transoral robotic surgery (TORS).
Study design: Retrospective review of the State Inpatient Database (SID), the State Ambulatory Surgery Database (SASD), and the State Emergency Department Database (SEDD) from the Healthcare Cost and Utilization Project.
Methods: Patients were identified from the SID, SASD, and SEDD for the states of Florida, New York, and California from 2005 to 2013 who had an International Classification of Diseases, Ninth Edition code for a surgical procedure on the upper aerodigestive tract associated with a code for robotic-assisted surgery. Univariate logistic regression was used to explore factors associated with POH.
Results: Five hundred nine patients underwent TORS. Indications for surgery included neoplastic disease in 376 (74%) and sleep apnea in 74 (15%). Forty-one (8%) had an episode of POH at a median of 9 days postoperatively (range = 0-21 days). Twenty-four (5%) required an intervention related to their POH. Sixteen (3%) required return to the operating room for control of hemorrhage; 11 (2%) had a severe complication that required embolization or tracheostomy. Charlson Comorbidity Score of ≥3 (odds ratio [OR] = 3.02, 95% confidence interval [CI] = 1.45-6.30) and a tonsillar neoplasm (OR = 1.96, 95% CI = 1.03-3.74) were significantly associated with POH.
Conclusions: The incidence of POH after TORS was low, and few of these patients had a severe complication related to this event. Medical comorbidity and tonsillar subsite may be independent risk factors for POH. These data provide a benchmark for informed decision making in TORS and a basis for further study.
Level of evidence: 4. Laryngoscope, 127:2287-2292, 2017.
Keywords: Transoral robotic surgery; head and neck cancer; obstructive sleep apnea; oropharynx; sleep medicine.
© 2017 The American Laryngological, Rhinological and Otological Society, Inc.
Similar articles
-
Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma.Head Neck. 2015 Nov;37(11):1618-24. doi: 10.1002/hed.23809. Epub 2014 Aug 28. Head Neck. 2015. PMID: 24955923
-
Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma.Head Neck. 2018 Nov;40(11):2416-2423. doi: 10.1002/hed.25362. Epub 2018 Aug 13. Head Neck. 2018. PMID: 30102813
-
The influence of perioperative enoxaparin on bleeding after TORS oropharyngectomy.J Robot Surg. 2024 May 7;18(1):203. doi: 10.1007/s11701-024-01965-z. J Robot Surg. 2024. PMID: 38713415
-
Transoral Robotic Surgical Proficiency Via Real-Time Tactile Collision Awareness System.Laryngoscope. 2020 Dec;130 Suppl 6:S1-S17. doi: 10.1002/lary.29034. Epub 2020 Aug 31. Laryngoscope. 2020. PMID: 32865822
-
Transoral robotic surgery and oropharyngeal cancer: a literature review.Ear Nose Throat J. 2014 Aug;93(8):E14-21. doi: 10.1177/014556131409300821. Ear Nose Throat J. 2014. PMID: 25181669 Review.
Cited by
-
Efficacy of Vascular Ligation for the Prevention of Intra- and Postoperative Bleeding in Transoral Robotic Surgery for Oropharyngeal Cancer.Cancers (Basel). 2025 Apr 25;17(9):1446. doi: 10.3390/cancers17091446. Cancers (Basel). 2025. PMID: 40361373 Free PMC article.
-
Robotic surgery of head and neck cancers, a narrative review.Eur J Transl Myol. 2020 Jan 17;30(2):8727. doi: 10.4081/ejtm.2019.8727. eCollection 2020 Jul 13. Eur J Transl Myol. 2020. PMID: 32782756 Free PMC article.
-
A systematic review on Transoral robotic surgery (TORS) for carcinoma of unknown primary origin: Has tongue base mucosectomy become indispensable?Clin Otolaryngol. 2020 Sep;45(5):732-738. doi: 10.1111/coa.13565. Epub 2020 May 25. Clin Otolaryngol. 2020. PMID: 32369264 Free PMC article.
-
Transoral endoscopy-assisted low-temperature plasma for the treatment of oropharyngeal malignant tumours: Preliminary Reports from a Single-Centre Retrospective Analysis.World J Surg Oncol. 2025 May 23;23(1):202. doi: 10.1186/s12957-025-03854-7. World J Surg Oncol. 2025. PMID: 40410912 Free PMC article.
-
Is the Da Vinci Xi system a real improvement for oncologic transoral robotic surgery? A systematic review of the literature.J Robot Surg. 2021 Feb;15(1):1-12. doi: 10.1007/s11701-020-01132-0. Epub 2020 Aug 4. J Robot Surg. 2021. PMID: 32749569
References
-
- Takes RP, Strojan P, Silver CE, et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 2012;34:270–281. - PubMed
-
- Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol 2009;266:1333–1352. - PubMed
-
- Moore EJ, Hinni ML. Critical review: transoral laser microsurgery and robotic-assisted surgery for oropharynx cancer including human papillomavirus-related cancer. Int J Radiat Oncol Biol Phys 2013;85: 1163–1167. - PubMed
-
- Pollei TR, Hinni ML, Moore EJ, et al. Analysis of postoperative bleeding and risk factors in transoral surgery of the oropharynx. JAMA Otolaryngol Head Neck Surg 2013;139:1212–1218. - PubMed
-
- Chia SH, Gross ND, Richmon JD. Surgeon experience and complications with transoral robotic surgery (TORS). Otolaryngol Head Neck Surg 2013;149:885–892. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials